Extract from M&A Insights

The below story was originally featured in our daily M&A Insights Newsletter. Selected stories, including this one, are posted to our website with some weeks of delay.
Abacus Medicine is preparing for possible IPO in 2018
June 1, 2018

Abacus Medicine supplies original prescription medicine in Europe through parallel import. In 2017 revenues grew 42% compared to 2016's 59%. The company is now looking to tap into the markets for unregistered drugs and the supply of pharmaceuticals for clinical trials, which are two markets with a total global value of more than DKK 50b. In order to do this, the company needs to raise funds and are highly considering an IPO in the near future according to Borsen.

ⓘ This story was originally featured in our daily M&A Insights newsletter.
Our insights have been covered by: